NSUN2-Mediated RNA 5-Methylcytosine Modification of PTEN Regulates Cognitive Impairments of Mice with Sleep Deprivation and Autophagy Through PI3K/AKT Signaling.
Gangli Yan, Yan Xu, Xiaobin Xing, Shuyue Chen, Fengguang Li
{"title":"NSUN2-Mediated RNA 5-Methylcytosine Modification of PTEN Regulates Cognitive Impairments of Mice with Sleep Deprivation and Autophagy Through PI3K/AKT Signaling.","authors":"Gangli Yan, Yan Xu, Xiaobin Xing, Shuyue Chen, Fengguang Li","doi":"10.1007/s12017-024-08823-z","DOIUrl":null,"url":null,"abstract":"<p><p>Sleep deprivation (SD) impairs learning and memory. Investigating the role of epigenetic modifications, such as 5-methylcytosine (m<sup>5</sup>C), in SD is crucial. This study established an SD mouse model and assessed the mRNA levels of m<sup>5</sup>C-related genes in brain tissue to identify potential candidates. Results indicated a significant elevation of NSUN2 in the SD group. Behavioral assessments using the Morris water maze test revealed cognitive impairments. Notably, inhibiting NSUN2 markedly alleviated these cognitive deficits and reduced autophagy in SD mice. Mechanistically, NSUN2 inhibition led to a pronounced decrease in PTEN levels, and the m<sup>5</sup>C modification of PTEN, which was increased by SD, was significantly reduced following NSUN2 knockdown. It was found that NSUN2 stabilizes PTEN mRNA through methylation. In the SD group, PTEN protein levels were elevated, and this increase was counteracted by NSUN2 inhibition. Collectively, the upregulation of PTEN may diminish the beneficial effects of NSUN2 inhibition on cognitive function and autophagy in SD mice. This study suggests that targeting NSUN2 and PTEN could be a novel therapeutic approach to ameliorate cognitive impairments and autophagy associated with SD, offering a promising strategy for the clinical management of SD-related cognitive deficits.</p>","PeriodicalId":19304,"journal":{"name":"NeuroMolecular Medicine","volume":"27 1","pages":"4"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroMolecular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12017-024-08823-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Sleep deprivation (SD) impairs learning and memory. Investigating the role of epigenetic modifications, such as 5-methylcytosine (m5C), in SD is crucial. This study established an SD mouse model and assessed the mRNA levels of m5C-related genes in brain tissue to identify potential candidates. Results indicated a significant elevation of NSUN2 in the SD group. Behavioral assessments using the Morris water maze test revealed cognitive impairments. Notably, inhibiting NSUN2 markedly alleviated these cognitive deficits and reduced autophagy in SD mice. Mechanistically, NSUN2 inhibition led to a pronounced decrease in PTEN levels, and the m5C modification of PTEN, which was increased by SD, was significantly reduced following NSUN2 knockdown. It was found that NSUN2 stabilizes PTEN mRNA through methylation. In the SD group, PTEN protein levels were elevated, and this increase was counteracted by NSUN2 inhibition. Collectively, the upregulation of PTEN may diminish the beneficial effects of NSUN2 inhibition on cognitive function and autophagy in SD mice. This study suggests that targeting NSUN2 and PTEN could be a novel therapeutic approach to ameliorate cognitive impairments and autophagy associated with SD, offering a promising strategy for the clinical management of SD-related cognitive deficits.
期刊介绍:
NeuroMolecular Medicine publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The information published in NEMM will provide a window into the future of molecular medicine for the nervous system.